Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Clinical trial NCT03435094 · UNKNOWN
Trial details
- NCT number
- NCT03435094
- Sponsor
- Labatec Pharma SA
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-02-25
- Primary completion
- 2022-03-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.